Generalizability of findings from efficacy trials for chronic depression: An analysis of eligibility criteria

Psychiatric Services

Volumn 65, Issue 7, 2014, Pages 897-904

  Von Wolff, Alessa ^a   Jansen, Malte ^b   Hölzel, Lars P ^c   Westphal, Annika ^a   Härter, Martin ^a   Kriston, Levente ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CHRONIC DEPRESSION; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; PATIENT CARE; PSYCHODYNAMIC PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUICIDE; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; CHRONIC DISEASE; DEPRESSIVE DISORDER; FEMALE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SELECTION; STANDARDS;

ADULT; CHRONIC DISEASE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84903766606     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201300309     Document Type: Article

References (36)

1. Satyanarayana S, Enns MW, Cox BJ, et al: Prevalence and correlates of chronic depression in the Canadian community health survey: mental health and well-being. Canadian Journal of Psychiatry 54:389-398, 2009
2. Berndt ER, Koran LM, Finkelstein SN, et al: Lost human capital from early-onset chronic depression. American Journal of Psychiatry 157:940-947, 2000 (Pubitemid 30412345)
3. Gilmer WS, Trivedi MH, Rush AJ, et al: Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica 112:425-433, 2005 (Pubitemid 41676686)
4. Browne G, Steiner M, Roberts J, et al: Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. Journal of Affective Disorders 68:317-330, 2002 (Pubitemid 34628336)
5. de Mello MF, Myczcowisk LM, Menezes PR: A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder. Journal of Psychotherapy Practice and Research 10:117-123, 2001 (Pubitemid 32240159)
6. Keller MB, McCullough JP, Klein DN, et al: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 342:1462-1470, 2000 (Pubitemid 30318269)
7. Kocsis JH, Gelenberg AJ, Rothbaum BO, et al; REVAMP Investigators: Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Archives of General Psychiatry 66:1178-1188, 2009
8. Markowitz JC, Kocsis JH, Bleiberg KL, et al: A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. Journal of Affective Disorders 89:167-175, 2005 (Pubitemid 41740844)
9. Miller IW, Norman WH, Keitner GI: Combined treatment for patients with double depression. Psychotherapy and Psychosomatics 68:180-185, 1999 (Pubitemid 29286905)
10. Ravindran AV, Anisman H, Merali Z, et al: Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. American Journal of Psychiatry 156:1608-1617, 1999 (Pubitemid 29459995)
11. Schramm E, Schneider D, Zobel I, et al: Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. Journal of Affective Disorders 109:65-73, 2008
12. Rothwell PM: External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 365:82-93, 2005
13. Green LW, Glasgow RE: Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Evaluation and the Health Professions 29:126-153, 2006 (Pubitemid 43797500)
14. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290:1624-1632, 2003 (Pubitemid 37430387)
15. Stirman SW, DeRubeis RJ, Crits-Christoph P, et al: Are samples in randomized controlled trials of psychotherapy representative of community outpatients? A new methodology and initial findings. Journal of Consulting and Clinical Psychology 71:963-972, 2003 (Pubitemid 37448886)
16. Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry 159:469-473, 2002 (Pubitemid 34184745)
17. Parker G: Antidepressants on trial: how valid is the evidence? British Journal of Psychiatry 194:1-3, 2009
18. Zimmerman M, Chelminski I, Posternak MA: Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. American Journal of Psychiatry 162:1370-1372, 2005 (Pubitemid 40905589)
19. van der Lem R, van der Wee NJA, van Veen T, et al: The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychological Medicine 41:1353-1363, 2011
20. Wisniewski SR, Rush AJ, Nierenberg AA, et al: Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. American Journal of Psychiatry 166:599-607, 2009
21. Zetin M, Hoepner CT: Relevance of exclusion criteria in antidepressant clinical trials: a replication study. Journal of Clinical Psychopharmacology 27:295-301, 2007 (Pubitemid 46763313)
22. Schindler AC, Hiller W, Witthöft M: Benchmarking of cognitive-behavioral therapy for depression in efficacy and effectiveness studies: how do exclusion criteria affect treatment outcome? Psychotherapy Research 21:644-657, 2011
23. van der Lem R, de Wever WWH, van der Wee NJA, et al: The generalizability of psychotherapy efficacy trials in major depressive disorder: an analysis of the influence of patient selection in efficacy trials on symptom outcome in daily practice. BMC Psychiatry 12:192, 2012
24. Hölzel LP, Härter M, Reese C, et al: Risk factors for chronic depression: a systematic review. Journal of Affective Disorders 129:1-13, 2011
25. Practice guideline for the treatment of patients with major depressive disorder. American Journal of Psychiatry 167(suppl 10):1-152, 2010
26. Depression: The Treatment and Management of Depression in Adults. National Clinical Practice Guideline 90. London, National Institute for Health and Clinical Excellence, 2009
27. Härter M, Klesse C, Bermejo I, et al: Evidence-based therapy of depression: S3 guidelines on unipolar depression [in German]. Der Nervenarzt 81:1049-1068, 2010
28. Fritze J: Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report [in German]. Der Nervenarzt 79:1337-1345, 2008
29. Kriston L, von Wolff A, Hölzel LP: Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON). BMC Psychiatry 10:95, 2010
30. von Wolff A, Hölzel LP, Westphal A, et al: Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. Journal of Affective Disorders 144:7-15, 2013
31. von Wolff A, Hölzel LP, Westphal A, et al: Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and metaanalysis. BMC Psychiatry, 2012; doi 10.1186/1471-244X-12-61
32. Schneider F, Härter M, Brand S, et al: Adherence to guidelines for treatment of depression in in-patients. British Journal of Psychiatry 187:462-469, 2005 (Pubitemid 41546577)
33. Cording C, Gaebel W, Spengler A, et al: The new psychiatric basic documentation: a recommendation of the DGPPN for quality insurance in inpatient treatment [in German]. Spektrum der Psychiatrie und Nervenheilkunde 24:3-41, 1995
34. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23:56-62, 1960
35. Muthén LK, Muthén BO: Mplus, Version 6.1. Los Angeles, Muthén and Muthén, 2011
36. Craig P, Dieppe P, Macintyre S, et al Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ, 2008; doi 10.1136/bmj.a1655